| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 18 | +50.00% | +1.18% | +0.67% | +0.51% | +0.88% | — |
| 14d | 18 | +22.22% | +2.75% | +1.75% | +1.00% | +2.60% | — |
| 30d | 18 | +61.11% | -2.26% | +2.31% | -4.58% | -7.80% | — |
| 60d | 18 | +44.44% | -4.98% | +3.50% | -8.48% | +2.05% | — |
| 90d | 18 | +61.11% | -9.27% | +2.62% | -11.89% | -12.97% | — |
| 180d | 18 | +72.22% | -9.52% | +10.45% | -19.96% | -19.32% | — |
| 1y | 18(5 pending) | +69.23% | +53.65% | +18.73% | +34.92% | -58.52% | — |
| 2y | 18(10 pending) | +62.50% | -19.16% | +43.66% | -62.82% | -106.61% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 13,600 | $33.37 | $453.9K | 421,290 | Jan 5, 2026 | Jan 5, 2026 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 31,961 | $32.29 | $1.03M | 434,890 | Jan 5, 2026 | Jan 5, 2026 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 10,500 | $34.22 | $359.3K | 410,790 | Jan 5, 2026 | Jan 5, 2026 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 1,600 | $35.07 | $56.1K | 409,190 | Jan 5, 2026 | Jan 5, 2026 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 91,000 | — | — | 91,000 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 32,049 | — | — | 466,851 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 41,000 | — | — | 434,802 | Jan 2, 2026 | Jan 5, 2026 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 6,185 | $35.00 | $216.5K | 382,467 | Oct 28, 2025 | Oct 28, 2025 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 11,117 | — | — | 388,652 | Oct 27, 2025 | Oct 28, 2025 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 4,266 | $27.77 | $118.5K | 377,535 | Jul 3, 2025 | Jul 3, 2025 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 7,667 | — | — | 381,801 | Jul 2, 2025 | Jul 3, 2025 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 49,115 | $42.69 | $2.10M | 379,234 | Jan 6, 2025 | Jan 6, 2025 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 5,100 | $43.32 | $220.9K | 374,134 | Jan 6, 2025 | Jan 6, 2025 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 37,200 | — | — | 37,200 | Jan 3, 2025 | Jan 6, 2025 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 21,667 | — | — | 428,349 | Jan 3, 2025 | Jan 6, 2025 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 44,533 | — | — | 406,682 | Jan 3, 2025 | Jan 6, 2025 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 14,704 | $56.98 | $837.8K | 365,471 | Jul 30, 2024 | Jul 31, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 3,322 | $57.82 | $192.1K | 362,149 | Jul 30, 2024 | Jul 31, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 10,000 | — | — | 358,508 | Jul 29, 2024 | Jul 31, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 21,667 | — | — | 380,175 | Jul 29, 2024 | Jul 31, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 105,343 | $78.65 | $8.28M | 474,702 | May 1, 2024 | May 2, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 17,999 | — | — | 1 | May 1, 2024 | May 2, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Operating Officer | 51,000 | $8.52 | $434.5K | 629,933 | May 1, 2024 | May 2, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 87,000 | — | — | 87,000 | May 1, 2024 | May 2, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 6,248 | $80.08 | $500.3K | 348,508 | May 1, 2024 | May 2, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 51,000 | — | — | 153,000 | May 1, 2024 | May 2, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Operating Officer | 35,426 | $7.77 | $275.3K | 578,933 | May 1, 2024 | May 2, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 26,142 | $77.49 | $2.03M | 580,045 | May 1, 2024 | May 2, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 35,426 | — | — | 18,574 | May 1, 2024 | May 2, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Operating Officer | 87,000 | $4.88 | $424.6K | 453,507 | May 1, 2024 | May 2, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 90,000 | — | — | 0 | May 1, 2024 | May 2, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Operating Officer | 17,999 | $4.68 | $84.2K | 366,507 | May 1, 2024 | May 2, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Operating Officer | 90,000 | $5.80 | $522.0K | 543,507 | May 1, 2024 | May 2, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 23,746 | $76.40 | $1.81M | 606,187 | May 1, 2024 | May 2, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE10b5-1 10b5-1 plan | 119,946 | $79.29 | $9.51M | 354,756 | May 1, 2024 | May 2, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 16,610 | $83.34 | $1.38M | 363,565 | Mar 27, 2024 | Mar 27, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 31,667 | — | — | 380,175 | Mar 27, 2024 | Mar 27, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 31,667 | — | — | 365,466 | Mar 1, 2024 | Mar 4, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 16,958 | $85.22 | $1.45M | 348,508 | Mar 1, 2024 | Mar 4, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 14,199 | $18.58 | $263.8K | 333,799 | Jan 4, 2024 | Jan 4, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 32,677 | $17.40 | $568.6K | 347,998 | Jan 3, 2024 | Jan 4, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 16,533 | $17.40 | $287.7K | 310,675 | Jan 3, 2024 | Jan 4, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 70,000 | — | — | 380,675 | Jan 3, 2024 | Jan 4, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 28,334 | — | — | 327,208 | Jan 3, 2024 | Jan 4, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 155,000 | — | — | 155,000 | Jan 3, 2024 | Jan 4, 2024 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 12,500 | $20.00 | $250.0K | 287,763 | Apr 17, 2023 | Apr 18, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Operating Officer | 12,500 | $13.07 | $163.4K | 300,263 | Apr 17, 2023 | Apr 18, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 12,500 | — | — | 0 | Apr 17, 2023 | Apr 18, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 23,100 | — | — | 0 | Mar 30, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 3,000 | — | — | 1,000 | Mar 30, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 30,799 | $17.57 | $541.1K | 287,763 | Mar 30, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 36,100 | $17.01 | $614.0K | 261,895 | Mar 30, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Operating Officer | 3,000 | $6.47 | $19.4K | 297,995 | Mar 30, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 56,667 | — | — | 318,562 | Mar 30, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Operating Officer | 10,000 | $7.69 | $76.9K | 294,995 | Mar 30, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Operating Officer | 23,100 | $8.52 | $196.8K | 284,995 | Mar 30, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 10,000 | — | — | 0 | Mar 30, 2023 | Apr 3, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Operating Officer | 15,000 | $9.13 | $136.9K | 303,137 | Mar 29, 2023 | Mar 30, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 15,000 | — | — | 0 | Mar 29, 2023 | Mar 30, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 41,242 | $16.00 | $659.9K | 261,895 | Mar 29, 2023 | Mar 30, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 30,000 | — | — | 0 | Mar 28, 2023 | Mar 30, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Operating Officer | 15,000 | $1.26 | $18.9K | 352,146 | Mar 28, 2023 | Mar 30, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Operating Officer | 15,000 | $1.08 | $16.2K | 420,200 | Mar 28, 2023 | Mar 30, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Operating Officer | 15,000 | $2.15 | $32.3K | 332,273 | Mar 28, 2023 | Mar 30, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Operating Officer | 4,873 | $1.88 | $9.2K | 337,146 | Mar 28, 2023 | Mar 30, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 10,000 | — | — | 0 | Mar 28, 2023 | Mar 30, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Operating Officer | 24,500 | $4.65 | $113.9K | 454,700 | Mar 28, 2023 | Mar 30, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 196,563 | $15.00 | $2.95M | 288,137 | Mar 28, 2023 | Mar 30, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 4,873 | — | — | 0 | Mar 28, 2023 | Mar 30, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Operating Officer | 53,054 | $1.23 | $65.3K | 405,200 | Mar 28, 2023 | Mar 30, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 53,054 | — | — | 0 | Mar 28, 2023 | Mar 30, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 15,000 | — | — | 0 | Mar 28, 2023 | Mar 30, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 24,500 | — | — | 0 | Mar 28, 2023 | Mar 30, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Operating Officer | 30,000 | $4.37 | $131.1K | 484,700 | Mar 28, 2023 | Mar 30, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Operating Officer | 10,000 | $1.04 | $10.4K | 430,200 | Mar 28, 2023 | Mar 30, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 1,079 | $8.95 | $9.7K | 317,273 | Jan 15, 2023 | Jan 17, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 13,994 | $8.42 | $117.8K | 318,352 | Jan 4, 2023 | Jan 4, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 204,000 | — | — | 204,000 | Jan 3, 2023 | Jan 4, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 18,854 | $8.52 | $160.6K | 332,346 | Jan 3, 2023 | Jan 4, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 90,667 | — | — | 351,200 | Jan 3, 2023 | Jan 4, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 23,500 | — | — | 273,306 | Dec 30, 2022 | Jan 4, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 12,773 | $9.40 | $120.1K | 260,533 | Dec 30, 2022 | Jan 4, 2023 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 827 | $4.24 | $3.5K | 238,695 | Jan 15, 2022 | Feb 11, 2022 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 11,845 | $4.62 | $54.7K | 239,522 | Jan 4, 2022 | Jan 5, 2022 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 3,919 | $4.88 | $19.1K | 174,034 | Jan 3, 2022 | Jan 5, 2022 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 77,333 | — | — | 251,367 | Jan 3, 2022 | Jan 5, 2022 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 174,000 | — | — | 174,000 | Jan 3, 2022 | Jan 5, 2022 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 6,667 | — | — | 180,374 | Sep 28, 2021 | Sep 30, 2021 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 2,839 | $6.50 | $18.5K | 177,535 | Sep 28, 2021 | Sep 30, 2021 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 994 | $6.68 | $6.6K | 169,952 | Jan 19, 2021 | Jan 19, 2021 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 686 | $6.48 | $4.4K | 170,946 | Jan 15, 2021 | Jan 19, 2021 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 90,000 | — | — | 90,000 | Jan 4, 2021 | Jan 6, 2021 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 73,000 | — | — | 167,655 | Jan 4, 2021 | Jan 6, 2021 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | SALE Chief Operating Officer | 2,773 | $5.80 | $16.1K | 171,632 | Jan 4, 2021 | Jan 6, 2021 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 6,750 | — | — | 174,405 | Jan 4, 2021 | Jan 6, 2021 ↗ | View → |